Your Australian patent application has been opposed – what next?
Australia’s pre‑grant opposition proceedings are playing a more significant role in the strategies of patentees and challengers. So what should a patent owner do when faced with an opposition in Australia?
Why are embryonic stem cells not able to be patented in Australia?
Despite not being specifically excluded under s18 of the Australian Patents Act, technology utilising embryonic stem cells is not able to be patented in Australia. Why is this so?
Spotlight Series: Regenerative Medicine – Part 1
The first in a five-part series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.
Draft roadmap for Australian regenerative medicine released for comment
AusBiotech has released a draft strategic roadmap for a new regenerative medicine Catalyst.
Guidance on patenting diagnostics in Australia: Ariosa Diagnostics v Sequenom
Federal Court confirms that a non-invasive diagnostic test for prenatal conditions is patentable subject matter in Australia.
Ono: Broader is not always better
Why is patent term extension is so important to companies developing and commercialising new pharmaceutical substances?